Financial Network Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Financial Network Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$109K	Buy	+854	New	+$116K	0.04%	159

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Financial Network Wealth Management's IBB Position: Q1 2025 in Review

Financial Network Wealth Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2025: 854 shares worth $109K. The stake represents 0.04% of the portfolio and ranks #159 among its holdings.

831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Financial Network Wealth Management held 854 shares of iShares Biotechnology ETF worth $109K as of Q1 2025.
iShares Biotechnology ETF was a new Financial Network Wealth Management position in Q1 2025.
iShares Biotechnology ETF made up 0.04% of Financial Network Wealth Management's portfolio in Q1 2025, its #159 holding.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Financial Network Wealth Management's 13F filing for Q1 2025, filed 29 Apr 2025.